Terril Brothers Has Cut Its Stake in Bank Amer (BAC) as Market Value Declined; Nantahala Capital Management Holds Position in Chemocentryx (CCXI)

January 6, 2018 - By Marie Mckinney

Terril Brothers Inc decreased its stake in Bank Amer Corp (BAC) by 1.43% based on its latest 2017Q3 regulatory filing with the SEC. Terril Brothers Inc sold 12,220 shares as the company’s stock declined 6.00% while stock markets rallied. The institutional investor held 839,874 shares of the major banks company at the end of 2017Q3, valued at $21.28 million, down from 852,094 at the end of the previous reported quarter. Terril Brothers Inc who had been investing in Bank Amer Corp for a number of months, seems to be less bullish one the $316.36 billion market cap company. The stock increased 0.46% or $0.14 during the last trading session, reaching $30.33. About 56.45M shares traded. Bank of America Corporation (NYSE:BAC) has risen 58.64% since January 6, 2017 and is uptrending. It has outperformed by 41.94% the S&P500.

Wilmot B. Harkey increased its stake in Chemocentryx Inc (CCXI) by 11.96% based on its latest 2017Q3 regulatory filing with the SEC. Nantahala Capital Management Llc bought 72,426 shares as the company’s stock declined 0.28% while stock markets rallied. The hedge fund run by Wilmot B. Harkey held 677,779 shares of the health care company at the end of 2017Q3, valued at $5.03M, up from 605,353 at the end of the previous reported quarter. Nantahala Capital Management Llc who had been investing in Chemocentryx Inc for a number of months, seems to be bullish on the $412.08M market cap company. The stock decreased 2.09% or $0.18 during the last trading session, reaching $8.45. About 606,490 shares traded or 428.63% up from the average. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 60.64% since January 6, 2017 and is uptrending. It has outperformed by 43.94% the S&P500.

Investors sentiment decreased to 1.14 in Q3 2017. Its down 0.26, from 1.4 in 2017Q2. It dropped, as 12 investors sold CCXI shares while 23 reduced holdings. 12 funds opened positions while 28 raised stakes. 23.75 million shares or 2.21% less from 24.29 million shares in 2017Q2 were reported. Millennium Mngmt Ltd Liability holds 0% or 218,762 shares. Keybank Natl Association Oh reported 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Moreover, Goldman Sachs Gru has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 220,440 shares. Voya Ltd Llc holds 15,984 shares or 0% of its portfolio. Amer Grp Inc Incorporated holds 0% or 16,364 shares. D E Shaw And Inc invested in 0% or 245,635 shares. Banque Pictet Cie Sa holds 0.01% or 54,178 shares in its portfolio. Nantahala Cap Mngmt Ltd Liability Corp reported 0.25% in ChemoCentryx, Inc. (NASDAQ:CCXI). Nationwide Fund Advsr accumulated 0% or 13,828 shares. Panagora Asset Inc holds 266,518 shares. California State Teachers Retirement accumulated 0% or 38,082 shares. Los Angeles Capital Equity holds 0% or 55,780 shares in its portfolio. Spark Invest Ltd Company has invested 0.07% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Credit Suisse Ag holds 18,040 shares or 0% of its portfolio. New York-based Renaissance Limited has invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI).

Since August 1, 2017, it had 0 insider purchases, and 1 sale for $22,667 activity.

Among 3 analysts covering ChemoCentryx (NASDAQ:CCXI), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. ChemoCentryx had 5 analyst reports since September 3, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, August 10 by JMP Securities. As per Tuesday, August 8, the company rating was maintained by Cowen & Co. The firm has “Sell” rating by Zacks given on Monday, September 21. JMP Securities initiated the stock with “Mkt Outperform” rating in Tuesday, February 21 report. The rating was downgraded by Zacks on Thursday, September 3 to “Sell”.

Nantahala Capital Management Llc, which manages about $614.40 million and $2.04B US Long portfolio, decreased its stake in Bridgepoint Ed Inc (NYSE:BPI) by 114,907 shares to 1.28 million shares, valued at $12.28M in 2017Q3, according to the filing. It also reduced its holding in Dolby Laboratories Inc (NYSE:DLB) by 128,110 shares in the quarter, leaving it with 774,397 shares, and cut its stake in Owens Rlty Mtg Inc (NYSEMKT:ORM).

Investors sentiment decreased to 1.04 in Q3 2017. Its down 0.08, from 1.12 in 2017Q2. It fall, as 68 investors sold BAC shares while 569 reduced holdings. 117 funds opened positions while 547 raised stakes. 6.91 billion shares or 9.01% more from 6.34 billion shares in 2017Q2 were reported. Wright Investors Service holds 0.89% of its portfolio in Bank of America Corporation (NYSE:BAC) for 96,440 shares. Moreover, Castleark Ltd Liability has 0.39% invested in Bank of America Corporation (NYSE:BAC). 81,100 are held by Argentiere Ag. Fishman Jay A Ltd Mi reported 0.58% stake. Ameriprise Fin Inc owns 60.67 million shares for 0.73% of their portfolio. Lathrop holds 0.15% or 21,108 shares in its portfolio. Nordea Invest Mngmt Ab owns 5.36 million shares. Cap Inv Ltd Com holds 417,133 shares or 0.73% of its portfolio. Needelman Asset Mgmt Inc invested in 3.97% or 63,836 shares. The United Kingdom-based Artemis Inv Management Llp has invested 2.72% in Bank of America Corporation (NYSE:BAC). 182.13 million were accumulated by Jpmorgan Chase. Pub Sector Pension Board stated it has 7.20M shares or 0.79% of all its holdings. Hudock Capital Gp Limited Company reported 30,227 shares. Shayne And Ltd Liability invested in 14,700 shares. Davidson & Garrard invested 2.08% of its portfolio in Bank of America Corporation (NYSE:BAC).

Analysts await Bank of America Corporation (NYSE:BAC) to report earnings on January, 17 before the open. They expect $0.46 earnings per share, up 15.00% or $0.06 from last year’s $0.4 per share. BAC’s profit will be $4.80 billion for 16.48 P/E if the $0.46 EPS becomes a reality. After $0.48 actual earnings per share reported by Bank of America Corporation for the previous quarter, Wall Street now forecasts -4.17% negative EPS growth.

Among 31 analysts covering Bank of America (NYSE:BAC), 21 have Buy rating, 0 Sell and 10 Hold. Therefore 68% are positive. Bank of America had 100 analyst reports since July 21, 2015 according to SRatingsIntel. Societe Generale upgraded the shares of BAC in report on Wednesday, January 11 to “Buy” rating. The firm earned “Hold” rating on Friday, September 29 by Robert W. Baird. The rating was downgraded by Wood on Monday, May 16 to “Market Perform”. The firm has “Buy” rating by Sandler O’Neill given on Wednesday, January 20. The rating was maintained by BMO Capital Markets on Friday, October 6 with “Hold”. The stock of Bank of America Corporation (NYSE:BAC) has “Outperform” rating given on Tuesday, November 29 by Keefe Bruyette & Woods. Robert W. Baird maintained Bank of America Corporation (NYSE:BAC) on Friday, August 25 with “Hold” rating. Vetr upgraded Bank of America Corporation (NYSE:BAC) rating on Monday, August 24. Vetr has “Buy” rating and $18.59 target. As per Tuesday, August 25, the company rating was maintained by Deutsche Bank. RBC Capital Markets maintained it with “Buy” rating and $2600 target in Wednesday, June 14 report.

Since August 10, 2017, it had 0 insider purchases, and 1 insider sale for $2.10 million activity.